CFG
ELI

Citizens Financial Group’s ELITE PHARMACEUTICAL ELI Stock Holding History

Citizens Financial Group’s Portfolio ELI Stock Details ELI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50,000
Closed -$5K – 877
2019
Q1 		$5K Buy
+50,000
New +$5K ﹤0.01% 611

Other funds holding ELI

JAFL
Jay A. Fishman Ltd Troy, Michigan $1.26B AUM 31.39% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Citizens Financial Group's ELI Position: Q2 2019 in Review

Citizens Financial Group sold out of ELITE PHARMACEUTICAL (ELI) in Q2 2019, closing a stake of 50,000 shares — an estimated $5K sold.

Citizens Financial Group first reported a position in ELI in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 2 funds tracked by Wall St. Rank hold ELI as of Q2 2019.

  • Citizens Financial Group reported no remaining ELITE PHARMACEUTICAL position as of Q2 2019 after selling out during the quarter.
  • Citizens Financial Group sold 50,000 ELITE PHARMACEUTICAL shares in Q2 2019, an estimated $5K.
  • Citizens Financial Group first reported a position in ELITE PHARMACEUTICAL in Q1 2019 and held it in 1 quarter.
  • Citizens Financial Group's ELITE PHARMACEUTICAL position peaked at $5K in Q1 2019.
  • 2 funds tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q2 2019.

Based on Citizens Financial Group's 13F filing for Q2 2019, filed 9 Aug 2019.